GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) » Definitions » Capex-to-Operating-Income

IOL Chemicals And Pharmaceuticals (BOM:524164) Capex-to-Operating-Income : 0.00 (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is IOL Chemicals And Pharmaceuticals Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

IOL Chemicals And Pharmaceuticals's Capital Expenditure for the three months ended in Sep. 2024 was ₹0.00 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₹236.30 Mil.

Hence, IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income for the three months ended in Sep. 2024 was 0.00.


IOL Chemicals And Pharmaceuticals Capex-to-Operating-Income Historical Data

The historical data trend for IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IOL Chemicals And Pharmaceuticals Capex-to-Operating-Income Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.20 0.71 1.18 1.63

IOL Chemicals And Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income falls into.



IOL Chemicals And Pharmaceuticals Capex-to-Operating-Income Calculation

IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-2741.7) / 1679.3
=1.63

IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 236.3
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IOL Chemicals And Pharmaceuticals  (BOM:524164) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


IOL Chemicals And Pharmaceuticals Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of IOL Chemicals And Pharmaceuticals's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


IOL Chemicals And Pharmaceuticals Business Description

Traded in Other Exchanges
Address
85, Industrial Area, 'A', Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.

IOL Chemicals And Pharmaceuticals Headlines

No Headlines